FCMI
Foresite Capital Management II Portfolio holdings
AUM
$29.2M
This Quarter Return
-1.13%
1 Year Return
+44.84%
3 Year Return
-66.21%
5 Year Return
-37.37%
10 Year Return
–
AUM
$284M
AUM Growth
+$284M
(+68%)
Cap. Flow
+$65M
Cap. Flow
% of AUM
22.86%
Top 10 Holdings %
Top 10 Hldgs %
86.35%
Holding
25
New
9
Increased
5
Reduced
4
Closed
4
Top Buys
1 |
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
|
$63.9M |
2 |
ADAP
Adaptimmune Therapeutics
ADAP
|
$32.2M |
3 |
UAM
Universal American Corp
UAM
|
$28.5M |
4 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$10.5M |
5 |
ALDR
Alder Biopharmaceuticals, Inc.
ALDR
|
$9.94M |
Top Sells
1 |
Larimar Therapeutics
LRMR
|
$93.5M |
2 |
ASPX
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
|
$7.52M |
3 |
TTOO
T2 Biosystems, Inc
TTOO
|
$3.62M |
4 |
AGRX
Agile Therapeutics, Inc
AGRX
|
$3.51M |
5 |
Sangamo Therapeutics
SGMO
|
$2.59M |
Sector Composition
1 | Healthcare | 91.81% |